Summary
Five9 reported record second-quarter revenue of $283.27 million, up 12.4% from the prior-year quarter. Gross profit rose 16.3% to $155.40 million. Gross margin expanded to 54.9% from 53.0%. Operating loss narrowed to $1.56 million from $19.36 million. Operating margin improved to -0.6% from -7.7%. Net income was $1.15 million, compared with a net loss of $12.82 million a year earlier. Diluted EPS was $0.01 versus a loss of $0.17. For the first six months, revenue was $562.97 million, up 12.8%. Gross profit was $309.14 million, up 16.2%. Gross margin was 54.9% versus 53.3%. Operating loss narrowed to $6.99 million from $40.06 million. Operating margin was -1.2% versus -8.0%. Net income was $1.73 million versus a net loss of $19.89 million. Diluted EPS was $0.02 versus a loss of $0.27.
Cash generation improved. Second-quarter operating cash flow was $35.06 million, up 76.4% from $19.88 million. Year-to-date operating cash flow was $83.44 million, up 59.8% from $52.23 million. Capital expenditures fell to $3.49 million from $6.77 million in the quarter. For the first six months, capital expenditures were $8.22 million, down 56.1% from $18.72 million. Deferred revenue was $68.01 million, up 4.2%. Remaining performance obligations were $1.15 billion, up 9.8%. The annual dollar-based retention rate was 108%, flat year over year. Subscription revenue grew 16% year over year. Enterprise AI revenue grew 42% year over year and represented 10% of Enterprise subscription revenue. Enterprise AI bookings more than tripled year over year.
Non-GAAP results also improved. Adjusted gross margin was 63.0% versus 60.5%. Non-GAAP net income was $58.3 million, or $0.76 per diluted share, compared with $38.9 million, or $0.52 per diluted share. Non-GAAP operating income was $54.5 million versus $31.0 million. Adjusted EBITDA was $67.9 million, or 24.0% of revenue, compared with $41.8 million, or 16.6% of revenue. Management said the quarter set a Q2 record for both operating and free cash flow.
Guidance points to continued growth. For the third quarter of 2025, Five9 expects revenue of $283.0 million to $286.0 million. Non-GAAP net income per share is guided to $0.72 to $0.74. For the full year 2025, revenue is guided to $1.1435 billion to $1.1495 billion. Non-GAAP net income per share is guided to $2.86 to $2.90. The company assumes diluted shares of approximately 87.5 million for third-quarter GAAP EPS, 78.1 million for third-quarter non-GAAP EPS, 88.5 million for full-year GAAP EPS, and 77.7 million for full-year non-GAAP EPS.
Cost actions and risks remain in focus. The 2025 reduction in force plan cut global full-time employees by approximately 4%. Five9 incurred $7.8 million in restructuring costs under that plan in the second quarter and first six months, plus $2.1 million in stock-based compensation. The 2024 plan reduced employees by approximately 6% and cost $9.6 million in 2024. As of June 30, 2025, the company had $692.6 million in working capital, including $205.5 million in cash and cash equivalents and $430.4 million in marketable investments. The 2025 convertible notes matured on June 1, 2025, and Five9 settled them with a $434.4 million cash payment. The 2029 convertible notes had $747.5 million in principal outstanding as of June 30, 2025. Management expects macroeconomic challenges, global tariff increases, the Russia-Ukraine conflict, and Middle East conflicts to keep pressuring revenue. The company also faces a securities class action filed on December 4, 2024, an amended complaint filed on May 30, 2025, and a motion to dismiss filed on July 29, 2025. A related derivative action is stayed. Five9 appointed Bryan Lee as chief financial officer effective July 31, 2025.
Forecast
Reported figures
GAAP, from SEC filings| Metric | Q2 FY2025 | Q1 FY2025 | QoQ | Q2 FY2024 | YoY |
|---|---|---|---|---|---|
| Revenue | $283.3M | $279.7M | +1.3% | $252.1M | +12.4% |
| Gross profit | $155.4M | $153.7M | +1.1% | $133.7M | +16.3% |
| Gross margin | 54.9% | 55.0% | -0.1 pp | 53.0% | +1.8 pp |
| Research & development | $39.9M | $41.1M | -2.9% | $40.7M | -2.0% |
| Sales & marketing | $80.7M | $82.9M | -2.6% | $78.3M | +3.0% |
| General & administrative | $36.4M | $35.2M | +3.4% | $34.0M | +7.1% |
| Total operating expenses | $157.0M | $159.2M | -1.4% | $153.0M | +2.6% |
| Operating income (loss) | -$1.6M | -$5.4M | +71.2% | -$19.4M | +91.9% |
| Operating margin | -0.6% | -1.9% | +1.4 pp | -7.7% | +7.1 pp |
| Net income (loss) | $1.2M | $576.0K | +100.3% | -$12.8M | +109.0% |
| Net margin | 0.4% | 0.2% | +0.2 pp | -5.1% | +5.5 pp |
| Diluted EPS | $0.01 | $0.01 | ±$0.00 | -$0.17 | +$0.18 |
| Customers | 3,000 | 3,000 | ±0.0% | — | — |
Risks
MD&A states the company expects macroeconomic challenges to continue to have an adverse impact on revenue in future periods, citing global tariff increases, the Russia-Ukraine conflict, and conflicts in the Middle East. It also says the installed base business continues to experience macroeconomic challenges despite increases in up-sells and cross-sells.
A putative securities class action filed December 4, 2024 against the company, its CEO, and its CFO remains pending; an amended complaint was filed May 30, 2025, and the company filed a motion to dismiss on July 29, 2025. A related shareholder derivative action is stayed, and the company cannot estimate the reasonably possible loss or range of losses.
Annual Dollar-Based Retention Rate was 108% for the twelve months ended June 30, 2025, flat versus 108% for the twelve months ended June 30, 2024. MD&A attributes the flat rate to continued macroeconomic headwinds, seasonal decreases in consumer and healthcare vertical markets, and a single large new customer ramping throughout 2024, offset by AI momentum and expansions of larger existing customers.
The 2025 Plan reduced global full-time employees by approximately 4% and incurred $7.8 million in restructuring costs plus $2.1 million in additional stock-based compensation during the three and six months ended June 30, 2025. The company is prioritizing investments in key strategic areas, including artificial intelligence, which may create execution and retention risk.
The 2025 convertible senior notes matured on June 1, 2025 and were settled with a $434.4 million cash payment, reducing cash and investments. As of June 30, 2025, $747.5 million aggregate principal of 2029 convertible senior notes remains outstanding, and interest expense increased 23% for the six months ended June 30, 2025 compared to the prior-year period.
SaaS KPIs
All quarters →Adjusted EBITDA
Adjusted EBITDA Margin
Adjusted Gross Margin
Total Customers
Non-GAAP Operating Income
Enterprise AI Revenue Growth
Non-GAAP Net Income
Non-GAAP Net Income Margin
Subscription Revenue Growth
Summary, forecast, risks and KPIs are extracted from Five9, Inc.'s SEC filings for Q2 FY2025 (10-Q / 10-K and the 8-K earnings release); GAAP figures in the summary are checked against the reported XBRL data. They can contain errors; the filings are authoritative. Processed Oct 1, 2026.